Ongoing Basser Center for BRCA research will impact care for generations of BRCA1 and BRCA2 carriers to come.
The goal of the Basser Center for BRCA is to learn from today's patients and better understand BRCA mutations. This ongoing research will impact care for generations of BRCA1 and BRCA2 carriers to come.
Patient participation in research studies led to the initial discovery of the BRCA1 and BRCA2 as well as the development of better strategies for managing cancer risks and ultimately treating cancers.
The Basser Center aims to deliver cutting edge research in basic and clinical sciences to advance the care of individuals carrying BRCA mutations.
Some of our studies are clinical trials that test novel therapies or interventions. Other studies are observational and individuals can often participate from afar.
Investigators at the Basser Center for BRCA publish in a wide range of peer-reviewed journals focused on all aspects of cancer and genetics.
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 1-800-789-PENN or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.